Insights from nanomedicine into chloroquine efficacy against COVID-19.
Identifieur interne : 001A55 ( Main/Corpus ); précédent : 001A54; suivant : 001A56Insights from nanomedicine into chloroquine efficacy against COVID-19.
Auteurs : Tony Y. Hu ; Matthew Frieman ; Joy WolframSource :
- Nature nanotechnology [ 1748-3395 ] ; 2020.
English descriptors
- KwdEn :
- Antiviral Agents (pharmacokinetics), Antiviral Agents (pharmacology), Antiviral Agents (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Chloroquine (pharmacokinetics), Chloroquine (pharmacology), Chloroquine (therapeutic use), Coronavirus Infections (drug therapy), Endocytosis (drug effects), Humans (MeSH), Hydrogen-Ion Concentration (MeSH), Hydroxychloroquine (pharmacokinetics), Hydroxychloroquine (pharmacology), Hydroxychloroquine (therapeutic use), Inflammation (MeSH), Nanomedicine (MeSH), Nanoparticles (MeSH), Pandemics (MeSH), Pneumonia, Viral (drug therapy), SARS-CoV-2 (MeSH), Spike Glycoprotein, Coronavirus (drug effects), Spike Glycoprotein, Coronavirus (metabolism), Virion (drug effects), Virus Replication (drug effects).
- MESH :
- chemical , drug effects : Spike Glycoprotein, Coronavirus.
- chemical , metabolism : Spike Glycoprotein, Coronavirus.
- chemical , pharmacokinetics : Antiviral Agents, Chloroquine, Hydroxychloroquine.
- chemical , pharmacology : Antiviral Agents, Chloroquine, Hydroxychloroquine.
- chemical , therapeutic use : Antiviral Agents, Chloroquine, Hydroxychloroquine.
- drug effects : Endocytosis, Virion, Virus Replication.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, COVID-19, Humans, Hydrogen-Ion Concentration, Inflammation, Nanomedicine, Nanoparticles, Pandemics, SARS-CoV-2.
DOI: 10.1038/s41565-020-0674-9
PubMed: 32203437
PubMed Central: PMC7094976
Links to Exploration step
pubmed:32203437Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Insights from nanomedicine into chloroquine efficacy against COVID-19.</title>
<author><name sortKey="Hu, Tony Y" sort="Hu, Tony Y" uniqKey="Hu T" first="Tony Y" last="Hu">Tony Y. Hu</name>
<affiliation><nlm:affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Frieman, Matthew" sort="Frieman, Matthew" uniqKey="Frieman M" first="Matthew" last="Frieman">Matthew Frieman</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfram, Joy" sort="Wolfram, Joy" uniqKey="Wolfram J" first="Joy" last="Wolfram">Joy Wolfram</name>
<affiliation><nlm:affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32203437</idno>
<idno type="pmid">32203437</idno>
<idno type="doi">10.1038/s41565-020-0674-9</idno>
<idno type="pmc">PMC7094976</idno>
<idno type="wicri:Area/Main/Corpus">001A55</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A55</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Insights from nanomedicine into chloroquine efficacy against COVID-19.</title>
<author><name sortKey="Hu, Tony Y" sort="Hu, Tony Y" uniqKey="Hu T" first="Tony Y" last="Hu">Tony Y. Hu</name>
<affiliation><nlm:affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Frieman, Matthew" sort="Frieman, Matthew" uniqKey="Frieman M" first="Matthew" last="Frieman">Matthew Frieman</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfram, Joy" sort="Wolfram, Joy" uniqKey="Wolfram J" first="Joy" last="Wolfram">Joy Wolfram</name>
<affiliation><nlm:affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature nanotechnology</title>
<idno type="eISSN">1748-3395</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (pharmacokinetics)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Chloroquine (pharmacokinetics)</term>
<term>Chloroquine (pharmacology)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Endocytosis (drug effects)</term>
<term>Humans (MeSH)</term>
<term>Hydrogen-Ion Concentration (MeSH)</term>
<term>Hydroxychloroquine (pharmacokinetics)</term>
<term>Hydroxychloroquine (pharmacology)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Inflammation (MeSH)</term>
<term>Nanomedicine (MeSH)</term>
<term>Nanoparticles (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (drug effects)</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>Virion (drug effects)</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Endocytosis</term>
<term>Virion</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>Inflammation</term>
<term>Nanomedicine</term>
<term>Nanoparticles</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32203437</PMID>
<DateCompleted><Year>2020</Year>
<Month>04</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1748-3395</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>15</Volume>
<Issue>4</Issue>
<PubDate><Year>2020</Year>
<Month>04</Month>
</PubDate>
</JournalIssue>
<Title>Nature nanotechnology</Title>
<ISOAbbreviation>Nat Nanotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Insights from nanomedicine into chloroquine efficacy against COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>247-249</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41565-020-0674-9</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hu</LastName>
<ForeName>Tony Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo><Affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Frieman</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wolfram</LastName>
<ForeName>Joy</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R21AI52318</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>R21EB026347</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>DODW8IXWH1910926</GrantID>
<Agency>U.S. Department of Defense (United States Department of Defense)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>R21 EB026347</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01AI113725</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>R01 AI113725</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HD090927</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01AI122932</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>R21 AI152318</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 AI122932</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21AI126361</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country>International</Country>
</Grant>
<Grant><GrantID>R21 AI126361</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01HD090927</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Nat Nanotechnol</MedlineTA>
<NlmUniqueID>101283273</NlmUniqueID>
<ISSNLinking>1748-3387</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050997" MajorTopicYN="N">Nanomedicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32203437</ArticleId>
<ArticleId IdType="doi">10.1038/s41565-020-0674-9</ArticleId>
<ArticleId IdType="pii">10.1038/s41565-020-0674-9</ArticleId>
<ArticleId IdType="pmc">PMC7094976</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Gao, J., Tian, Z. & Yang, X. Biosci. Trends https://doi.org/10.5582/bst.2020.01047 (2020).</Citation>
</Reference>
<Reference><Citation>Wang, M. et al. Cell Res. 30, 269–271 (2020).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0282-0</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhu, N. et al. N. Engl. J. Med. 382, 727–733 (2020).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Haladyj, E., Sikora, M., Felis-Giemza, A. & Olesinska, M. Reumatologia 56, 164–173 (2018).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.5114/reum.2018.76904</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Savarino, A., Boelaert, J. R., Cassone, A., Majori, G. & Cauda, R. Lancet Infect. Dis. 3, 722–727 (2003).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(03)00806-5</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Keyaerts, E. et al. Antimicrob. Agents Chemother. 53, 3416–3421 (2009).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01509-08</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vincent, M. J. et al. Virol. J. 2, 69 (2005).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-2-69</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hempelmann, E. Parasitol. Res. 100, 671–676 (2007).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1007/s00436-006-0313-x</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pelt, J. et al. Pharmacol. Ther. 191, 43–49 (2018).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.06.007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wolfram, J. et al. Sci Rep 7, 13738 (2017).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14221-2</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Miller, S. E. et al. Dev. Cell 33, 163–175 (2015).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2015.03.002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wolfram, J. & Ferrari, M. Nano Today 25, 85–89 (2019).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/j.nantod.2019.02.005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gentile, E. et al. Future Oncol. 9, 1849–1859 (2013).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.2217/fon.13.146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wu, K., Li, W., Peng, G. & Li, F. Proc. Natl Acad. Sci. USA 106, 19970–19974 (2009).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908837106</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Li, W. et al. Nature 426, 450–454 (2003).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wang, H. et al. Cell Res. 18, 290–301 (2008).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/cr.2008.15</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Inoue, Y. et al. J. Virol. 81, 8722–8729 (2007).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00253-07</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wrapp, D. et al. Science 367, 1260–1263 (2020).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Yao, X. et al. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa237 (2020).</Citation>
</Reference>
<Reference><Citation>Liu, J. et al. Cell Discov. 6, 16 (2020).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0156-0</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dowall, S. D. et al. J. Gen. Virol. 96, 3484–3492 (2015).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000309</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Madrid, P. B. et al. PLoS One 8, e60579 (2013).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060579</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Roques, P. et al. Viruses 10, 268 (2018).</Citation>
<ArticleIdList><ArticleId IdType="doi">10.3390/v10050268</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001A55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32203437 |texte= Insights from nanomedicine into chloroquine efficacy against COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32203437" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |